VivoSim Labs, Inc. Adjustments to Additional Paid in Capital, Other
VivoSim Labs, Inc. (VIVS) reported Adjustments to Additional Paid in Capital, Other of $2.60 thousand for the 6-month period ending 2011-12-31, per its 10-Q filed 2012-01-17.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2012-01-17
- VivoSim Labs, Inc. adjustments to additional paid in capital, other for the quarter ending 2011-12-31 was $1.30K.
- VivoSim Labs, Inc. adjustments to additional paid in capital, other for the quarter ending 2011-09-30 was $1.30K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 6 month | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|---|---|
| 2011-12-31 | $1.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-01-17 | $2.60K 10-Q · filed 2012-01-17 | |
| 2011-09-30 | $1.30K 10-Q · filed 2011-10-31 | ||
| 2011-06-30 | $5.20K 10-Q · filed 2012-01-17 | ||
| 2010-06-30 | $2.80K 10-Q · filed 2012-01-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |